article · Luminescence
A sensitive, sustainable, and effortless turn off-on fluorescent sensor was constructed for rapid determination of the non hromophoric drug, enoxaparin sodium (ENX). Enoxaparin is an anticoagulant utilized as a blood thinner for the treatment and prophylaxis of pulmonary embolism and deep vein thrombosis. The developed sensing platform depends on the quenching of salicylate fluorescence at 410 nm after excitation at 299 nm upon addition of ferric ammonium sulfate. The ability of ENX to displace salicylate from ferric salicylate chelate leads to restoration of salicylate fluorescence. Implementation of Box-Behnken Design (BBD) helps in optimization of different experimental parameters. A linear response was attained over a range of concentrations of ENX 0.4-2.0 μg/mL (equivalent to 0.09-0.43 μM) with detection and quantitation limits of 0.1 and 0.3 μg/mL, respectively. The developed platform was successfully employed for estimation of ENX in injection dosage form with mean recovery of 100.11 ± 1.24. The environmental sustainability of this sensor was assessed using various tools for greenness, blueness, violetness, and whiteness. Furthermore, the adherence to different sustainability development goals (SDGs) was proved.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1002/bio.70498
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.